Advanced Biomed Inc. Common Stock (ADVB) Earnings History
Annual and quarterly earnings data from 2021 to 2025
Loading earnings history...
ADVB EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
ADVB Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
Download Data
Export ADVB earnings history in CSV or JSON format
Free sign-in required to download data
Advanced Biomed Inc. Common Stock (ADVB) Earnings Overview
As of May 8, 2026, Advanced Biomed Inc. Common Stock (ADVB) reported trailing twelve-month net income of -$2M, reflecting +96.6% year-over-year growth. The company earned $-0.11 per diluted share over the past four quarters.
Looking at the long-term picture, ADVB's historical earnings data spans multiple years. The company achieved its highest annual net income of -$101,524 in fiscal 2025, representing a new all-time high.
Advanced Biomed Inc. Common Stock is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including AGEN ($115,000 net income, 0.1% margin), IMVT (-$464M net income), KROS ($87M net income, 35.7% margin), ADVB has comparable earnings metrics. Compare ADVB vs AGEN →
ADVB Earnings vs Peers
Earnings metrics vs comparable public companies
ADVB Historical Earnings Data (2021–2025)
5 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $-101,524 | +96.4% | $-94,112 | $-0.00 | - | - |
| 2024 | -$3M | +25.5% | -$3M | $-0.14 | - | - |
| 2023 | -$4M | +7.3% | -$3M | $-0.19 | - | - |
| 2022 | -$4M | -119.2% | -$2M | $-0.28 | - | - |
| 2021 | -$2M | - | -$2M | $-0.16 | - | - |
See ADVB's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ADVB Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ADVB vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonADVB — Frequently Asked Questions
Quick answers to the most common questions about buying ADVB stock.
Is ADVB growing earnings?
ADVB EPS is $-0.11, with earnings growth accelerating to +96.6%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-2M.
What are ADVB's profit margins?
Advanced Biomed Inc. Common Stock net margin is N/A, with operating margin at N/A. Below-average margins reflect competitive or cost pressures.
How consistent are ADVB's earnings?
ADVB earnings data spans 2021-2025. The accelerating earnings trend is +96.6% YoY. Historical data enables comparison across business cycles.